Cognitive Neuropsychiatry
Susan Rossell
INTRODUCTION
This group aims to characterise the cognitive deficits associated
with symptoms present in psychiatric disorders. A better understanding
of cognition can then be used to assist with designing new and more
effective treatments or psychological interventions. A psychosocial
interventions subgroup assists with direct translation of research
into psychosocial treatments.
Symptoms of psychiatric disorders include unusual beliefs or delusions,
hearing voices or hallucinations and impaired thinking or thought
disorder. Individuals who experience psychosis have a range of cognitive
difficulties that affect language, memory and high level functions.
These cognitive deficits have, in some cases, been linked to underlying
brain abnormalities.
In the last year, the clinical registry within the Cognitive Neuropsychiatry
Unit has grown. As well as patients with schizophrenia and bipolar
disorder the registry now includes individuals with Alzheimer’s
disease. 145 people are currently registered on the patient registry
and 108 on the control registry.
HIGHLIGHTS
The Belief Formation Project
Delusions are false beliefs, sometimes with bizarre content, that
are held with strong conviction even in the presence of contrary
evidence. Delusions occur in a range of severe psychiatric and neurological
disorders, and are experienced by 90% of schizophrenia patients
and 25% of bipolar affective disorder patients.
The most commonly experienced delusions in schizophrenia include
the belief that people are conspiring against you or trying to harm
you (delusions of persecution), and the belief that non-specific
social information is particularly relevant to you, or being directed
at you (delusions of reference). Other prevalent delusions in schizophrenia
include those with grandiose and/or religious themes (e.g. the belief
that you are Jesus Christ), or the belief that alien forces are
controlling your thoughts and actions (delusions of control).
Research has suggested individuals with delusions have deficits
in reasoning, emotion processing and defaults in their real world
knowledge. To date, most of this research has been carried out on
patients with schizophrenia. Susan Rossell’s team is currently extending
this work to examine other mental disorders including bipolar affective
disorder, body dysmorphic disorder, anorexia nervosa, Alzheimer’s
disease and first-episode psychotic patients. By investigating a
range of disorders which are associated with delusions, it is hoped
that a more comprehensive cognitive explanation of delusions, independent
of other associated symptoms, can be established.
Schizophrenia and bipolar disorder
Recruitment and testing for the Belief Formation Project was completed
in patients with schizophrenia and bipolar disorder. Data analysis
is now underway. Preliminary data was presented at the Australian
Society for Psychiatric Research in December 2006. As predicted,
our data established that abnormal reasoning is not an adequate
explanation for delusion formation, and that disturbed emotion processing
is prevalent in those with delusions.
To extend our understanding of emotion processing deficits in delusions
and develop our results on perceptual organization deficits, Nicole
Joshua has devised a series of further visual processing experiments
for her PhD. She aims to examine the hierarchy of procedures used
when processing visual information in patients with schizophrenia
and healthy controls; using tasks ranging from processing simple
line drawings to complex scenes that include faces. From this data
we hope to gain a greater understanding of why people with schizophrenia
have difficulties processing more complex visual stimuli (e.g. correctly
identifying emotions in faces). Nicole has tested 23 schizophrenia
patients, 20 bipolar disorder patients and 20 healthy control participants
and will finalise testing over the next few months.
Body dysmorphic disorder
Body dysmorphic disorder (BDD) is a preoccupation with an imagined
deficit or a slight physical anomaly in appearance which causes
significant distress or impairment in social, occupational or other
important areas of functioning.
Surprisingly, there have been few studies to investigate cognitive
functioning in BDD. Judy Dunai (for her Masters in Clinical Psychology)
and Izelle Labuschagne, in collaboration with David Castle and Mike
Kyrios, have embarked upon a detailed investigation of the cognitive
processes involved in belief formation in individuals with BDD.
Data collection is now complete and shows that patients with BDD
have significant difficulty accurately detecting facial emotions.
In January 2007, Wei Lin Toh joined us to extend this research.
She is examining whether deficits in facial affect processing are
the result of selective attentional biases or a problem with eye
scanning abilities. An ethics submission for this project has just
been completed.
Anorexia nervosa
Anorexia Nervosa (AN) is a chronic eating disorder characterised
by excessive fear of becoming overweight, body image disturbance,
significant weight loss and the refusal to gain weight or maintain
a minimal normal weight for age and height. The beliefs that people
with AN hold about their bodies are usually characterised as overvalued
ideas (an unreasonable and sustained belief that is held without
delusional intensity).
In a recent review of the nature of delusions, delusional intensity
is conceptualised as being multi-dimensional; varying on dimensions
such as conviction, preoccupation, distress and action. Defining
beliefs in AN as overvalued ideas rather than delusions suggests
that such beliefs are not held with the same degree of conviction,
preoccupation and fixity as delusions in psychotic disorders. However,
the intense fear of and refusal for weight gain that characterise
AN, despite malnutrition and impaired health status, may imply otherwise.
No study has examined (a) whether the beliefs in AN share the same
features as psychotic delusions, or (b) whether similar cognitive
deficits are shared by both disorders. Rachel Mountjoy will be examining
these two questions for her Doctorate of Clinical Psychology. Ethics
approval has now been gained for this project and recruiting commenced
in June 2007.
Alzheimer’s disease
Alzheimer’s disease (AD) is a progressive brain disorder that gradually
destroys a person’s memory and ability to learn, reason, make judgements,
communicate and carry out daily activities. We are familiar with
memory loss as a symptom of the disease; however the illness is
much more complex. As AD progresses, individuals may also experience
changes in personality and behaviour, such as anxiety, suspiciousness
or agitation; as well as delusions.
Delusions have recently been reported to be a common symptom in
AD and are associated with a number of adverse outcomes; for example,
greater aggression, caregiver stress and earlier institutionalisation
or dependence for daily living activities. Yet, there has been limited
research in this field. There is a poor understanding of the types
of delusions experienced in AD, their frequency, and the demographic
and cognitive risk factors. Furthermore, there is no consensus as
to what role stage of organic disease plays on the presence of delusions,
which in turn means that there has been no study to address the
neurobiological changes involved in the generation of delusional
beliefs in AD. Funded by a Claudia Wright Scholarship, David O’Connor
will address these gaps in our understanding for his PhD.
First episode psychosis
As part of her Masters in Clinical Psychology, Clare Cameron will
be investigating whether the deficits in knowledge or semantic processing
reported in Dr Rossell’s work are also present at first presentation
of a psychotic episode. This will help clarify whether semantic
deficits seen in schizophrenia patients are due to a developmental
problem, a slow disintegration where deficits first show at the
first signs of psychosis, or medication chronicity.
The results of this study will have implications for clinical treatment:
if semantic processing abnormalities are not present in first-onset
psychosis patients, steps can be taken to prevent the deterioration
of semantic processing. Recruiting for this project commenced in
early 2007. Clare is supervised by Susan Rossell and Lisa Phillips.
Gender, oestrogen and sensory information processing
Dr Andrea Gogos is collaborating with Susan Rossell on a project
examining the interaction of gender, oestrogen and brain mechanisms
that alter sensory information processing in men and women with
schizophrenia and bipolar disorder. In this study, participant performance
on various cognitive measures, such as memory, attention and information
processing, is compared.
A second, follow-up study is being conducted in healthy women to
specifically investigate the effects of endogenous oestrogen levels
on cognitive function and sensory information processing. In this
study, women are tested at various stages of the menstrual cycle,
where oestrogen levels dramatically rise and fall. Andrea is also
examining the interaction between exogenous oestrogen and serotonin
on sensory information processing in healthy women. These studies
are ongoing and are supported by funding from the Joan and Peter
Clemenger Trust.
Understanding Auditory Hallucinations
Hallucinations in psychosis are predominately auditory in nature.
Previous research has shown that patients with auditory hallucinations
(AH) have deficits in central auditory processing. The Cognitive
Neuropsychiatry group has established that this may be the result
of reduced interhemispheric connectivity; a theory that has resulted
in several publications.
In December 2006 we secured funding from the Rebecca L Cooper Medical
Research Foundation to continue work in this area and welcomed a
new PhD student, Chris Groot. Chris will be examining whether we
can further classify central auditory processing deficits to more
basic auditory perceptual abilities, for example whether individuals
who hear voices have problems with pitch or loudness perception.
Primary Auditory Cortex
The Impaired Thought Project
Disorganised thinking and speech, or ‘formal thought disorder’,
has been argued by some to be one of the most important symptoms
of schizophrenia and, along with hallucinations and delusions, is
certainly a cardinal feature.
To date, there has been no satisfactory cognitive explanation for
thought disorder. Approaches have emphasised the relationship between
semantic processing abnormalities and thought disorder. However,
Dr Rossell speculates that this provides an over-simplistic explanation,
and it is likely that a single cognitive deficit does not account
for thought disorder but that multiple deficits affecting specific
levels of linguistic processing (e.g. syntax, semantics and ‘fluency
or executive control’) are involved. Ongoing funding from a NARSAD
Young Investigator Award is assisting Susan to examine this hypothesis.
TORCH (Treatment of Resistant Command Hallucinations) Project
Command hallucinations (CHs) are a form of auditory hallucination
(AH) sometimes experienced by individuals with schizophrenia and
related psychoses that instruct the person to perform an action(s).
Command hallucinations are associated with significant levels of
disability and distress.
Over the past year, we have completed a trial of a psychological
treatment for CHs that works alongside antipsychotic medication
to help people cope with these symptoms. TORCH is a form of Cognitive
Behaviour Therapy that has been adapted for command hallucinations
and incorporates cutting edge developments in psychological therapies.
It comprises 15 sessions with a therapist. Our trial compared TORCH
with a control condition, ‘Befriending’, in which participants received
an equivalent amount of therapist contact, without the active therapeutic
components of TORCH. We are currently analysing results for publication.
The Voices Clinic
We have established a specialist treatment service for auditory
hallucinations. With support from The William Buckland Foundation,
we are piloting the Voices Clinic: a specialist service which receives
referrals from clinical services throughout Victoria.
Unique in Australia, the clinic is run by Dr Neil Thomas, an expert
in the psychological treatment of schizophrenia. There is a clear
need for this type of service, given a shortfall in the availability
of psychological treatments for patients with severe mental illness.
The clinic is a tertiary service which provides evidence-based psychological
treatment to patients, alongside their regular treatment from public
mental health services or private psychiatrists. Treatment comprises
regular one-to-one therapy sessions for up to six months, aiming
to reduce levels of distress and disability associated with auditory
hallucinations.
In addition to providing direct treatment, the Voices Clinic provides
training to mental health practitioners across Victoria in the form
of training workshops and supervision. Through such professional
development activities we hope to improve access to this important
treatment. The Voices Clinic has formed partnerships with a number
of public mental health services to whom it provides regular specialist
supervision in the psychological treatment of psychotic symptoms.
We are currently investigating the ongoing running of the clinic
following the pilot period in conjunction with public mental health
services.
|